Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$5,393,306
+$171,090 QoQ
Shares Held
21,236
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.55%
of 13F equity value
Holder Rank
#1,561
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Newman Dignan & Sheerar, Inc. holds $16,082,023 across 8 Drug Manufacturers - General names. JNJ ranks #1 (33.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
21,236 | $5,393,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
28,738 | $3,692,833 | |
| 3 | AMGN |
Amgen Inc
|
7,582 | $2,745,593 | |
| 4 | LLY |
ELI LILLY & Co
|
1,043 | $1,251,005 | |
| 5 | ABBV |
AbbVie Inc.
|
4,147 | $1,043,551 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,344 | $999,361 | |
| 7 | NVS |
Novartis AG
|
3,499 | $548,363 | |
| 8 | PFE |
Pfizer Inc
|
16,944 | $408,011 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,393,306 | 21,236 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $5,222,216 | 21,364 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $4,573,801 | 22,101 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $4,027,322 | 21,720 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $3,503,168 | 22,934 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $3,371,381 | 23,312 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $3,957,829 | 24,422 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,567,619 | 24,409 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $3,896,061 | 24,629 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $4,020,224 | 25,649 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,934,089 | 25,259 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,341,424 | 26,229 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $4,098,510 | 26,442 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $5,178,671 | 29,316 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $4,793,472 | 29,343 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $5,196,960 | 29,277 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $5,253,983 | 29,645 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $5,072,567 | 29,652 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $4,852,267 | 30,045 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $4,934,621 | 29,954 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $4,939,867 | 30,057 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,697,163 | 29,846 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $4,539,500 | 30,491 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $4,279,933 | 30,434 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $4,533,000 | 307,024 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||